FIELD: medicine.
SUBSTANCE: method involves introducing bio-organic animal preparation in advance during 4 days at daily intramuscular dose of 0.3 per 100 g of animal mass, before introducing cancerogenic agent. Then, the cancerogenic agent injections are started and continued during 30 days.
EFFECT: increased tissular resistance, antitumor immunity and phagocytic macrophage activity.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING MAMMARY GLAND CARCINOMA IN EXPERIMENT | 2005 |
|
RU2291497C1 |
| OPTIMIZATION TECHNIQUE FOR VENTER ENDOMETRIOSIS TREATMENT IN CLINICAL TRIAL | 2007 |
|
RU2336884C1 |
| METHOD FOR PREVENTION OF CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410093C1 |
| METHOD OF PREVENTING CANCEROGENIC ACTION OF METHYLNITROSOUREA IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410114C1 |
| AGENT FOR CANCER PROPHYLAXIS | 2005 |
|
RU2290178C1 |
| METHOD OF TREATING MALIGNANCIES IN MAMMALS | 2011 |
|
RU2461566C1 |
| METHOD OF INCREASING ANTI-TUMOUR RESISTANCE | 2009 |
|
RU2418599C1 |
| PHARMACEUTICAL FORMULATION FOR METASTASIS PREVENTION AND INCREASING OF TUMOUR SENSITISATION TO CHEMOTHERAPEUTIC AGENTS | 2007 |
|
RU2328282C1 |
| APPLICATION OF 9-OCOACRIDINE-10-ACETIC ACID AND/OR ITS SALT COMBINED WITH ANTIESTROGEN AND/OR PROGESTIN FOR TREATMENT OF STROGEN-DEPENDENT TUMOURS, METHOD OF TREATMENT AND SETS | 2007 |
|
RU2346691C2 |
| METHOD OF MODELING N-NITROSO-N-METHYLUREA-INDUCED BREAST CANCER IN RATS AGAINST THE BACKGROUND OF CHRONIC HYPERESTROGENEMIA | 2022 |
|
RU2798037C1 |
